C12N 2710/10344
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2710/10344 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 61 US grants and 88 published applications in this corpus.
Search patents in C12N- Granted patents
- 61
- Published applications
- 88
- Assignees
- 62
- Inventors
- 177
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 7 | 1 |
| 2002 | 6 | 11 |
| 2003 | 6 | 12 |
| 2004 | 2 | 7 |
| 2005 | 3 | 5 |
| 2006 | 7 | 6 |
| 2007 | 3 | 4 |
| 2008 | 1 | 1 |
| 2009 | 4 | 4 |
| 2010 | 2 | 2 |
| 2011 | 1 | 4 |
| 2012 | 3 | 2 |
| 2013 | 0 | 6 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 2 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 4 |
| 2023 | 1 | 5 |
| 2024 | 0 | 2 |
| 2025 | 1 | 3 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for selective gene regulation6 Jan 2026US 12,516,350 B2Encoded Therapeutics, Inc.
- Oncolytic virus expressing interferon and application therefor3 Jun 2025US 12,319,931 B2Shanghai Yuansong Biotechnology Co. Ltd.
- Compositions and methods comprising improvements of CRISPR guide RNAS using the H1 promoter26 Sep 2023US 11,766,488 B2The Johns Hopkins University
- Adenovirus derived helper virus for enhancing recombinant parvovirus production31 Oct 2017US 9,803,219 B2Deutsches Krebsforschungszentrum
- Adeno-parvovirus chimera with enhanced oncolytical potential13 Sep 2016US 9,441,246 B2Deutsches Krebsforschungszentrum
- Adenoviral helper plasmid16 Jul 2026US 2026/0201418 A1Forge Biologics, Inc.
- Compositions and methods for selective gene regulation19 Mar 2026US 2026/0078404 A1Encoded Therapeutics, Inc.
- System for High-Level rAAV Production8 Jan 2026US 2026/0009048 A1Charite-Universitaetsmedizin Berlin
- Adenovirus-based nucleic acids and methods thereof11 Sep 2025US 2025/0283054 A1Askbio Inc.
- Recombinant chimeric adenoviral vector substituted by knob gene of chimpanzee adenovirus serotype 6, and application thereof4 Sep 2025US 2025/0277234 A1Genematrix Inc.
Most cited
By later US patents
- Hybrid adenovirus-AAV virus and methods of use thereof311US 5,871,982 AThe Trustees of the University of Pennsylvania · 1999
- Hybrid adenovirus-AAV virus and methods of use thereof198US 6,251,677 B1The Trustees of the University of Pennsylvania · 2001
- Chimpanzee adenovirus vectors155US 6,083,716 AThe Trustees of the University of Pennsylvania · 2000
- Compositions and methods for helper-free production of recombinant adeno-associated viruses144US 6,485,966 B2The Trustees of the University of Pennsylvania · 2002
- Compositions and methods for helper-free production of recombinant adeno-associated viruses144US 7,022,519 B2The Trustees of the University of Pennsylvania · 2006